Stock Track | Zai Lab Ltd Plummets 5.3% Intraday on Monday as it Announces Public Offering of Shares

Stock Track11-18

Zai Lab Ltd (ZLAB) saw its stock price plummet 5.3% intraday on Monday, following the company's announcement of a public offering of American Depositary Shares (ADSs). The biopharmaceutical company stated that it expects to close the underwritten public offering of 7,843,137 ADSs at a price of $25.50 per ADS, with underwriters fully exercising their option to purchase an additional 1,176,470 ADSs.

The public offering is expected to result in gross proceeds of approximately $230 million for Zai Lab, before deducting underwriting discounts, commissions, and other expenses. The company plans to use the proceeds for general corporate purposes, including funding research and development activities and working capital needs.

While public offerings often dilute existing shareholders' stakes and put short-term pressure on stock prices, investors may view Zai Lab's move as a strategic decision to raise capital for future growth initiatives and product development. The biopharmaceutical firm, focused on oncology, immunology, neuroscience, and infectious disease treatments, could benefit from the additional funds to advance its pipeline and commercial activities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1131590090?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-18 23:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131590090","market":"hk","top_or_hot":-1,"title":"Stock Track | Zai Lab Ltd Plummets 5.3% Intraday on Monday as it Announces Public Offering of Shares","media":"Stock Track","content":"<p>Zai Lab Ltd (ZLAB) saw its stock price plummet 5.3% intraday on Monday, following the company's announcement of a public offering of American Depositary Shares (ADSs). The biopharmaceutical company stated that it expects to close the underwritten public offering of 7,843,137 ADSs at a price of $25.50 per ADS, with underwriters fully exercising their option to purchase an additional 1,176,470 ADSs.</p>\n\n<p>The public offering is expected to result in gross proceeds of approximately $230 million for Zai Lab, before deducting underwriting discounts, commissions, and other expenses. The company plans to use the proceeds for general corporate purposes, including funding research and development activities and working capital needs.</p>\n\n<p>While public offerings often dilute existing shareholders' stakes and put short-term pressure on stock prices, investors may view Zai Lab's move as a strategic decision to raise capital for future growth initiatives and product development. The biopharmaceutical firm, focused on oncology, immunology, neuroscience, and infectious disease treatments, could benefit from the additional funds to advance its pipeline and commercial activities.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Zai Lab Ltd Plummets 5.3% Intraday on Monday as it Announces Public Offering of Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Zai Lab Ltd Plummets 5.3% Intraday on Monday as it Announces Public Offering of Shares\n</h2>\n\n<h4 class=\"meta\">\n\n2024-11-18 23:40 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Zai Lab Ltd (ZLAB) saw its stock price plummet 5.3% intraday on Monday, following the company's announcement of a public offering of American Depositary Shares (ADSs). The biopharmaceutical company ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZLAB","symbol_name":"再鼎医药","start_time":0,"source_url":"","article_id":"1131590090","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131590090","pubTimestamp":1731944448,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Zai Lab Ltd  saw its stock price plummet 5.3% intraday on Monday, following the company's announcement of a public offering of American Depositary Shares . The biopharmaceutical company stated that it expects to close the underwritten public offering of 7,843,137 ADSs at a price of $25.50 per ADS, with underwriters fully exercising their option to purchase an additional 1,176,470 ADSs.The public offering is expected to result in gross proceeds of approximately $230 million for Zai Lab, before de","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ZLAB":"再鼎医药"},"translate_title":"股票轨迹再鼎医药宣布公开发行股票周一盘中暴跌5.3%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZLAB":1},"content_text":"Zai Lab Ltd (ZLAB) saw its stock price plummet 5.3% intraday on Monday, following the company's announcement of a public offering of American Depositary Shares (ADSs). The biopharmaceutical company stated that it expects to close the underwritten public offering of 7,843,137 ADSs at a price of $25.50 per ADS, with underwriters fully exercising their option to purchase an additional 1,176,470 ADSs.\nThe public offering is expected to result in gross proceeds of approximately $230 million for Zai Lab, before deducting underwriting discounts, commissions, and other expenses. The company plans to use the proceeds for general corporate purposes, including funding research and development activities and working capital needs.\nWhile public offerings often dilute existing shareholders' stakes and put short-term pressure on stock prices, investors may view Zai Lab's move as a strategic decision to raise capital for future growth initiatives and product development. The biopharmaceutical firm, focused on oncology, immunology, neuroscience, and infectious disease treatments, could benefit from the additional funds to advance its pipeline and commercial activities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1131590090"}